Change - Announcement of Appointment::Appointment of Independent Director

Issuer & Securities

Issuer/ Manager
OEL (HOLDINGS) LIMITED
Securities
OEL (HOLDINGS) LIMITED - SG0584008601 - 584
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
16-Oct-2020 18:03:28
Status
New
Announcement Sub Title
Appointment of Independent Director
Announcement Reference
SG201016OTHREVTF
Submitted By (Co./ Ind. Name)
Zhao Xin
Designation
Chief Executive Officer and Executive Director
Description (Please provide a detailed description of the event in the box below)
Appointment of Toh Lim Kai as an Independent Director of the Company.

This announcement has been reviewed by the Company's sponsor, RHT Capital Pte. Ltd. ("Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("SGX-ST"). The Sponsor has not independently verified the contents of this announcement.

This announcement has not been examined by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The details of the contact person for the Sponsor are:

Name: Mr Shervyn Essex (Registered Professional, RHT Capital Pte. Ltd.)
Address: 9 Raffles Place, #29-01 Republic Plaza Tower 1, Singapore 048619
Tel: 6381 6966

Additional Details

Date Of Appointment
17/10/2020
Name Of Person
Toh Lim Kai
Age
44
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Board of Directors, having considered the assessment and recommendation by the Nominating Committee, and having reviewed and considered Dr Toh Lim Kai's professional qualifications, work experiences and expertise, is of the view that Dr Toh Lim Kai posseses the requisite experience and capabilities to assume the role as an Independent Director of the Company.
Whether appointment is executive, and if so, the area of responsibility
The appointment is non-executive.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director, AC Member, RC Member and NC Member
Professional qualifications
Membership Royal College of Surgeons Ireland
MB. BCh. BAO (Honours) from Royal College of Surgeon in Ireland
MSc (Pharmaceutical Medical) from Hibernia College (Dublin)
Singapore MOH accredited Family Physician
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
1. Resident Physician, T Medical Clinic, 2018 to present
2. Regional Medical Director (APAC region), VIIV Healthcare - HIV medicine (Project base), 2019 to 2020
3. Regional Medical Director (South Asia), GE Healthcare - Pharmaceutical / Diagnostic Imaging, 2015 to 2017
4. Regional Medical Director (JAPAC region), AbbVie/Abbott - Virology / Neonatology, 2012 to 2015
5. Medical Manager (Pfizer Singapore), 2009 to 2012
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
1. Regional Medical Director (APAC region), VIIV Healthcare - HIV medicine (Project base) , 2019 to 2020
2. Director, TS Medical Pte. Ltd., 2018 to 2019
3. Regional Medical Director (South Asia), GE Healthcare Pharmaceutical / Diagnostic Imaging, 2015 to 2017
4. Regional Medical Director (JAPAC region), AbbVie/ Abbott - Virology / Neonatology, 2012 to 2015
Present
1. Resident Physician, T Medical Clinic
2. Director, T Medical Clinic (City Gate) Pte. Ltd.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Dr Toh Lim Kai will be attending the training courses conducted by the Singapore Institute of Directors to familiarise himself with the roles and responsibilities as a Director of a public company listed in Singapore.